ARTICLE | Distillery Therapeutics
Therapeutics: CTLA-4 (CD152)
October 29, 2015 7:00 AM UTC
In vitro and mouse studies suggest a cell-permeable peptide conjugated to a CTLA-4 domain could help treat MS. In the experimental autoimmune encephalomyelitis (EAE) mouse model of MS, pretreatment or...